ProShare Advisors’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.8K Buy
+10,241
New +$72.2K ﹤0.01% 1793
2026
Q1
Sell
-12,719
Closed -$104K 1880
2025
Q4
$104K Buy
+12,719
New +$115K ﹤0.01% 1868
2025
Q2
Sell
-11,313
Closed -$61.3K 2086
2025
Q1
$61.3K Sell
11,313
-3,406
-23% -$16.1K ﹤0.01% 1926
2024
Q4
$67.3K Buy
+14,719
New +$75.4K ﹤0.01% 2139
2021
Q3
Sell
-10,011
Closed -$124K 2025
2021
Q2
$124K Buy
+10,011
New +$119K ﹤0.01% 2256

Other funds holding AVAH

ProShare Advisors's AVAH Position: Q2 2026 in Review

ProShare Advisors opened a new position in Aveanna Healthcare (AVAH) in Q2 2026: 10,241 shares worth $87.8K. The stake represents ﹤0.01% of the portfolio and ranks #1793 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in AVAH as recently as Q4 2025.

ProShare Advisors first reported a position in AVAH in Q2 2021 and has held it in 5 quarters since. The position peaked at $124K in Q2 2021. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • ProShare Advisors held 10,241 shares of Aveanna Healthcare worth $87.8K as of Q2 2026.
  • Aveanna Healthcare was a new ProShare Advisors position in Q2 2026.
  • Aveanna Healthcare made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1793 holding.
  • ProShare Advisors first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 5 quarters since.
  • ProShare Advisors's Aveanna Healthcare position peaked at $124K in Q2 2021.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.